Clinical trials
Hematologic Neoplasms trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 7 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 6 |
| Terminated | 6 |
| Unknown status | 5 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| Novartis Pharmaceuticals | 3 |
| AbbVie | 2 |
| Hadassah Medical Organization | 2 |
| Janssen Research & Development, LLC | 2 |
| AGC Biologics S.p.A. | 1 |
| Bristol-Myers Squibb | 1 |
| Cellect Biotechnology | 1 |
| Cellphire Therapeutics, Inc. | 1 |
| Curis, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 32 |
| Lymphoma, Non-Hodgkin | 6 |
| Leukemia, Myeloid, Acute | 5 |
| Lymphoma | 5 |
| Myelodysplastic Syndromes | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Neoplasms | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Hodgkin Disease | 3 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.